Quick Answer
Viridian Therapeutics, Inc.DE reported Total Assets of $899.42 million for the year ending 2025.
- Viridian Therapeutics, Inc.DE showed an increase of +21.1% in Total Assets from 2024 to 2025.
- This data is from Viridian Therapeutics, Inc.DE's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $10.66 million | Q3 2014: $9.52 million | Q1 2015: $15.75 million | Q2 2015: $13.09 million | Q3 2015: $14.80 million | Q1 2016: $10.80 million | Q2 2016: $9.04 million | Q3 2016: $7.54 million | Q1 2017: $57.79 million | Q2 2017: $50.03 million | Q3 2017: $47.08 million | Q1 2018: $86.99 million | Q2 2018: $81.89 million | Q3 2018: $76.55 million | Q1 2019: $54.95 million | Q2 2019: $48.78 million | Q3 2019: $38.81 million | Q1 2020: $39.05 million | Q2 2020: $33.49 million | Q3 2020: $32.83 million | Q1 2021: $122.83 million | Q2 2021: $118.20 million | Q3 2021: $221.21 million | Q1 2022: $183.17 million | Q2 2022: $169.81 million | Q3 2022: $440.58 million | Q1 2023: $386.64 million | Q2 2023: $351.47 million | Q3 2023: $328.76 million | Q1 2024: $630.38 million | Q2 2024: $585.66 million | Q3 2024: $771.90 million | Q1 2025: $660.98 million | Q2 2025: $582.32 million | Q3 2025: $577.14 million.
- Over the full 13 years of available data (2013 to 2025), Viridian Therapeutics, Inc.DE's Total Assets has grown by 24,387.3%.
- Historical annual values: Fiscal year 2025: $899.42 million | Fiscal year 2024: $742.40 million | Fiscal year 2023: $490.42 million | Fiscal year 2022: $435.09 million | Fiscal year 2021: $203.71 million | Fiscal year 2020: $131.26 million | Fiscal year 2019: $30.26 million | Fiscal year 2018: $66.15 million | Fiscal year 2017: $52.48 million | Fiscal year 2016: $24.76 million | Fiscal year 2015: $12.90 million | Fiscal year 2014: $8.09 million | Fiscal year 2013: $3.67 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: